China: A recent study revealed that combining semaglutide and metformin significantly improved liver inflammation, fibrosis, ...

An intensive treatment approach to lowering high systolic blood pressure in people with Type 2 diabetes led to a reduced risk ...

A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among ...

New Delhi: GPT Healthcare Ltd shares listed with a premium of over 16 percent on Thursday against the issue price of Rs 186.

Researchers have established that hypoalbuminemia is an independent and strong predictor for both short- and long-term ...

People with severe, treatment-resistant depression who received a nerve-stimulating therapy showed significant improvement in ...

Age related macular degeneration (AMD) is the leading cause of vision loss in individuals over 65, characterized by abnormal ...

A new study published in The Laryngoscope journal showed that possibilities for cochlear implantation (CI) are growing as ...

The Parliamentary Standing Committee on Chemicals and Fertilisers has slammed the National Pharmaceutical Pricing Authority ...

New Delhi: BDR Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug ...

Prophylactic Trimetazidine may prevent contrast induced AKI in patients undergoing CAG or PCI suggests a study published in ...

China: A new randomized clinical trial has demonstrated that QX004N, a humanized anti–IL–23 monoclonal antibody, offers ...